Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 6ARU | Q8TCD0 | Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain | |
| 6NZ7 | Q8TCD0 | Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968 | Hemagglutinin HA1 chain, Hemagglutinin HA2 chain, 429 B01 FAB heavy chain, 429 B01 FAB light chain |
| 6NZ7 | Q8TCD0 | Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968 | Hemagglutinin HA1 chain, Hemagglutinin HA2 chain, 429 B01 FAB heavy chain, 429 B01 FAB light chain |
| 7CZS | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 5VOD | Q8TCD0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
| 5VOD | Q8TCD0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
| 5W42 | Q8TCD0 | Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2) | |
| 5W42 | Q8TCD0 | Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2) | |
| 6E4X | Q8TCD0 | Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2) | Hemagglutinin HA1, Lineage K03.12 UCA antibody heavy chain, Lineage K03.12 UCA antibody light chain |
| 6E4X | Q8TCD0 | Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2) | Hemagglutinin HA1, Lineage K03.12 UCA antibody heavy chain, Lineage K03.12 UCA antibody light chain |
| 7CZV | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VL3 | Q8TCD0 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain |
| 5VL3 | Q8TCD0 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain |
| 6BKC | Q8TCD0 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B | |
| 6BKC | Q8TCD0 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B | |
| 6DC5 | Q8TCD0 | RSV prefusion F in complex with AM22 Fab | |
| 6DC5 | Q8TCD0 | RSV prefusion F in complex with AM22 Fab | |
| 7D00 | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 1HZH | Q8TCD0 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN) |
| 1HZH | Q8TCD0 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN) |
| 3PGF | Q8TCD0 | Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB) | |
| 3PGF | Q8TCD0 | Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB) | |
| 7CZX | Q8TCD0 | S protein of SARS-CoV-2 in complex bound with P5A-1B9 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 5TIB | Q8TAX9 | Gasdermin-B C-terminal domain containing the polymorphism residues Arg299:Ser306 fused to maltose binding protein | |
| 5TJ2 | Q8TAX9 | Gasdermin-B C-terminal domain containing the polymorphism residues Gly299:Ser306 fused to maltose binding protein | |
| 5TJ4 | Q8TAX9 | Gasdermin-B C-terminal domain containing the polymorphism residues Gly299:Pro306 fused to maltose binding protein | |
| 6VFU | Q8TAB3 | Crystal structure of human protocadherin 19 EC1-EC4 | |
| 4JNO | Q8T9N3 | Crystal structure of Plasmodium falciparum Erythrocyte Binding Antigen 140 (PfEBA-140/BAEBL) Region II in complex with sialyllactose | BAEBL protein |
| 3K1L | Q8T913 | Crystal Structure of FANCL | |
| 4G2U | Q8T8F4 | Crystal Structure Analysis of Ostertagia ostertagi ASP-1 | |
| 6NRW | Q8T603 | Crystal structure of Dpr1 IG1 bound to DIP-eta IG1 | |
| 6XRX | Q8T5C5 | Crystal structure of the mosquito protein AZ1 as an MBP fusion | |
| 3AI0 | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with para-nitrophenyl-beta-D-glucopyranoside | |
| 3VIF | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with gluconolactone | |
| 3VIJ | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with glucose | |
| 3VIK | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with cellobiose | |
| 3VIL | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with salicin | |
| 3VIM | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with a new glucopyranosidic product | |
| 3VIN | Q8T0W7 | Crystal structure of beta-glucosidase from termite Neotermes koshunensis in complex with a new glucopyranosidic product | |
| 5F84 | Q8T045 | Crystal structure of Drosophila Poglut1 (Rumi) complexed with its glycoprotein product (glucosylated EGF repeat) and UDP | O-glucosyltransferase rumi (E.C.2.4.1.-), Coagulation factor IX (E.C.3.4.21.22) |
| 3MBF | Q8SSM8 | Crystal structure of fructose bisphosphate aldolase from Encephalitozoon cuniculi, bound to fructose 1,6-bisphosphate | |
| 4F4O | Q8SPS7 | Structure of the Haptoglobin-Haemoglobin Complex | |
| 1ZBV | Q8SPQ0 | Crystal Structure of the goat signalling protein (SPG-40) complexed with a designed peptide Trp-Pro-Trp at 3.2A resolution | |
| 1ZBW | Q8SPQ0 | Crystal structure of the complex formed between signalling protein from goat mammary gland (SPG-40) and a tripeptide Trp-Pro-Trp at 2.8A resolution | |
| 1ZU8 | Q8SPQ0 | Crystal structure of the goat signalling protein with a bound trisaccharide reveals that Trp78 reduces the carbohydrate binding site to half | |
| 2DSZ | Q8SPQ0 | Three dimensional structure of a goat signalling protein secreted during involution | |
| 2DT0 | Q8SPQ0 | Crystal structure of the complex of goat signalling protein with the trimer of N-acetylglucosamine at 2.45A resolution | |
| 2DT1 | Q8SPQ0 | Crystal Structure Of The Complex Of Goat Signalling Protein With Tetrasaccharide At 2.09 A Resolution |
